Home > Healthcare > Anticoagulants Market > Table of Contents

Anticoagulants Market - By Drug Class (Factor Xa Inhibitors, Heparin), Route of Administration (Oral, Injectables), Application (Thromboembolism, Atrial Fibrillation, Coronary Artery Disease), Distribution Channel & Global Forecast, 2023 – 2032

  • Report ID: GMI4967
  • Published Date: Jun 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market definition

1.2    Base estimates & calculations

1.3    Forecast parameters

1.4    COVID-19 impact analysis at global level

1.5    Data validation

1.6    Data Sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Public sources

Chapter 2   Executive Summary

2.1    Anticoagulants industry 360º synopsis, 2018 – 2032

2.1.1    Business trends

2.1.2    Regional trends

2.1.3    Drug category trends

2.1.4    Route of administration trends

2.1.5    Application trends

2.1.6    Distribution channel trends

Chapter 3   Anticoagulants Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Growing prevalence of chronic disease

3.2.1.2   Growing adoption of novel oral anticoagulants (NOACs)

3.2.1.3   Rising geriatric population across the globe

3.2.2    Industry pitfalls & challenges

3.2.2.1   High risk of side effects

3.2.2.2   Stringent regulatory framework

3.3    Growth potential analysis

3.3.1    By drug category

3.3.2    By route of administration

3.3.3    By application

3.3.4    By distribution channel

3.4    COVID- 19 impact analysis

3.5    Regulatory landscape

3.6    Porter's analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Anticoagulants Market Size and Forecast, By Drug Category (USD Million)

5.1    Key trends, by drug category

5.2    Factor Xa inhibitor

5.3    Heparin

5.4    Warfarin

5.5    Direct thrombin inhibitor

5.6    Others

Chapter 6   Anticoagulants Market Size and Forecast, By Route of Administration (USD Million)

6.1    Key trends, by route of administration

6.2    Oral

6.3    Injectable

Chapter 7   Anticoagulants Market Size and Forecast, By Application (USD Million)

7.1    Key trends, by application

7.2    Venous thromboembolism

7.3    Atrial fibrillation/flutter

7.4    Coronary artery disease

7.5    Others

Chapter 8   Anticoagulants Market Size and Forecast, By Distribution Channel (USD Million)

8.1    Key trends, by distribution channel

8.2    Hospital pharmacy

8.3    Retail pharmacy

8.4    Online pharmacy

Chapter 9   Anticoagulants Market Size and Forecast, By Region (USD Million)

9.1    Key trends, by region

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Rest of Europe

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.4.5    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.5.4    Rest of Latin America

9.6    Middle East & Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    UAE

9.6.4    Rest of Middle East & Africa

Chapter 10   Company Profiles

10.1    Bristol-Myers Squibb Company

10.2    Bayer AG

10.3    Boehringer Ingelheim

10.4    Johnson and Johnson

10.5    Daiichi Sankyo Company

10.6    Amphastar Pharmaceuticals, Inc.

10.7    Leo pharma

10.8    Pfizer

10.9    ROVI

10.10    Sanofi

10.11    Shenzhen Hepalink

10.12    United Therapeutics
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 276
  • Countries covered: 21
  • Pages: 181
 Download PDF